Table 1. Clinical severity according to age and sex in children with HSP.
Incidence (per 1,000 children with HSP) | HR | 95% CIs | |||
---|---|---|---|---|---|
Hospitalization | |||||
Total | 20.556 | ||||
Male | 22.511 | ||||
Female | 18.664 | 0.856 | 0.811–0.904 | ||
0–8 yr | 26.484 | ||||
9–17 yr | 11.408 | 0.455 | 0.426–0.486 | ||
Re-hospitalization | |||||
After 3 months | |||||
Total | 3.449 | ||||
Male | 3.448 | ||||
Female | 3.450 | 0.999 | 0.879–1.135 | ||
0–8 yr | 3.644 | ||||
9–17 yr | 3.124 | 0.868 | 0.758–0.993 | ||
After 6 months | |||||
Total | 2.867 | ||||
Male | 2.857 | ||||
Female | 2.876 | 1.003 | 0.869–1.158 | ||
0–8 yr | 2.991 | ||||
9–17 yr | 2.660 | 0.899 | 0.773–1.045 | ||
After 12 months | |||||
Total | 2.222 | ||||
Male | 2.197 | ||||
Female | 2.246 | 1.022 | 0.862–1.212 | ||
0–8 yr | 2.387 | ||||
9–17 yr | 1.946 | 0.822 | 0.686–0.985 | ||
Comorbidity | |||||
Intussusception | |||||
Male | 0.643 | ||||
Female | 0.450 | 0.733 | 0.534–1.007 | ||
0–8 yr | 0.813 | ||||
9–17 yr | 0.102 | 0.129 | 0.070–0.238 | ||
Abdominal intervention | |||||
Male | 0.153 | ||||
Female | 0.110 | 0.750 | 0.394–1.428 | ||
0–8 yr | 0.189 | ||||
9–17 yr | 0.037 | 0.202 | 0.072–0.569 | ||
HSP arthritis | |||||
Male | 0.433 | ||||
Female | 0.463 | 1.103 | 0.781–1.558 | ||
0–8 yr | 0.600 | ||||
9–17 yr | 0.195 | 0.328 | 0.205–0.523 | ||
HSP nephritis | |||||
Male | 2.413 | ||||
Female | 2.043 | 0.849 | 0.726–0.993 | ||
0–8 yr | 2.413 | ||||
9–17 yr | 1.916 | 0.809 | 0.685–0.955 |
HSP = Henoch-Schӧnlein purpura, HR = hazard ratio, CI = confidence interval.